Product Name | Medroxyprogesterone Base |
Synonyms | Medroxyprogesterone |
CAS | 520-85-4 |
Molecular Formula | C22H32O3 |
Molecular Weight | 344.49 |
Density | 1.0906g/cm3 |
Melting Point | 204-206°C |
Boiling Point | 419.57°C |
Refractive Index | 1.5 |
Storage | Room temperature |
Appearance | White Crystal Powder |
Medroxyprogesterone (INN, BAN), also known as 17α-hydroxy-6α-methylprogesterone, and abbreviated as MP, is a steroidal progestin drug which was never marketed for use in humans. An acylated derivative, medroxyprogesterone acetate (MPA), is clinically used as a pharmaceutical medicine. Compared to MPA, MP is over two orders of magnitude less potent as a progestogen. As such, MP itself is not used clinically, though it has seen limited use in veterinary medicine under the trade name Controlestril in France. In addition, it is a metabolite of MPA.
1) It is mostly used in the treatment of advanced breast cancer, endometrial adenocarcinoma and kidneycancer.
2) It is also used in dysmenorrheal, functional amenorrhea, dysfunctional uterine bleeding, threatenedabortion.
Estrogens | |
Estrone | 53-16-7 |
β-estradiol | 50-28-2 |
Estriol | 50-27-1 |
Estradiol Cypionate | 313-06-4 |
Estradiol Valerate | 979-32-8 |
Estradiol Benzoate | 50-50-0 |
Estradiol Enanthate | 4956-37-0 |
Estradiol Benzoate Butyrate | 63042-18-2 |
Estradiol Hexahydrobenzoate | 15140-27-9 |
Estradiol Dipropionate | 113-38-2 |
2-Methoxyestradiol | 362-07-2 |
β-Estradiol 17-acetate | 1743-60-8 |
Progestins | |
Progesterone | 57-83-0 |
Medroxyprogesterone Acetate | 71-58-9 |
Megestrol Acetate | 595-33-5 |
Altrenogest | 850-52-2 |
Dienogest | 65928-58-7 |
Mifepristone | 84371-65-3 |
17a-hydroxyprogesterone caproate | 630-56-8 |
Melengestrol Acetate | 2919-66-6 |
Allylestrenol | 432-60-0 |
Norgesterone | 13563-60-5 |
Ulipristal Acetate | 126784-99-4 |
Medroxyprogesterone Base | 520-85-4 |